Concept |
DECOR id |
DECOR effectiveDate |
FHIR id |
FHIR definition |
FHIR type |
Demografische gegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.1 |
2017-03-30T15:30:34 |
onco-generic-dataelement-1 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-1 |
group |
Patiënt |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.2 |
2017-03-30T15:30:34 |
onco-generic-dataelement-2 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-2 |
group |
Naamgegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.3 |
2017-03-30T15:30:34 |
NL-CM-0.1.6 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.6 |
group |
Initialen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.4 |
2017-03-30T15:30:34 |
NL-CM-0.1.35 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.35 |
string |
Geslachtsnaam |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.5 |
2017-03-30T15:30:34 |
NL-CM-0.1.36 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.36 |
group |
Achternaam |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.6 |
2017-03-30T15:30:34 |
NL-CM-0.1.24 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.24 |
string |
PatientIdentificatienummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.7 |
2017-03-30T15:30:34 |
NL-CM-0.1.7 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.7 |
string |
Geboortedatum |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.8 |
2017-03-30T15:30:34 |
NL-CM-0.1.10 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.10 |
dateTime |
Geslacht |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.9 |
2017-03-30T15:30:34 |
NL-CM-0.1.9 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.9 |
choice |
Zorgaanbieder |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.10 |
2017-03-30T15:30:34 |
NL-CM-17.2.1 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.1 |
group |
ZorgaanbiederIdentificatieNummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.11 |
2017-03-30T15:30:34 |
NL-CM-17.2.2 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.2 |
string |
OrganisatieNaam |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.12 |
2017-03-30T15:30:34 |
NL-CM-17.2.3 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.3 |
string |
AfdelingSpecialisme |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.13 |
2017-03-30T15:30:34 |
NL-CM-17.2.7 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.7 |
choice |
TelefoonEmail |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.14 |
2017-03-30T15:30:34 |
NL-CM-17.2.6 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.6 |
group |
Contactgegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.15 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3414 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3414 |
group |
Telefoonnummers |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.16 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3415 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3415 |
group |
Telefoonnummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.17 |
2017-03-30T15:30:34 |
NL-CM-0.1.23 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.23 |
string |
NummerSoort |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.18 |
2017-03-30T15:30:34 |
NL-CM-0.1.22 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.22 |
choice |
EmailAdressen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.19 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3418 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3418 |
group |
EmailAdres |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.20 |
2017-03-30T15:30:34 |
NL-CM-0.1.20 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.20 |
string |
EmailSoort |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.21 |
2017-03-30T15:30:34 |
NL-CM-0.1.19 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.19 |
choice |
Adres |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.22 |
2017-03-30T15:30:34 |
NL-CM-17.2.5 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.5 |
group |
Adresgegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.23 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3421 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3421 |
group |
Straat |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.24 |
2017-03-30T15:30:34 |
NL-CM-0.1.12 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.12 |
string |
Huisnummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.25 |
2017-03-30T15:30:34 |
NL-CM-0.1.13 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.13 |
string |
Huisnummerletter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.26 |
2017-03-30T15:30:34 |
NL-CM-0.1.40 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.40 |
string |
Huisnummertoevoeging |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.27 |
2017-03-30T15:30:34 |
NL-CM-0.1.41 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.41 |
string |
AanduidingBijNummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.28 |
2017-03-30T15:30:34 |
NL-CM-0.1.42 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.42 |
choice |
Postcode |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.29 |
2017-03-30T15:30:34 |
NL-CM-0.1.15 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.15 |
string |
Woonplaats |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.30 |
2017-03-30T15:30:34 |
NL-CM-0.1.14 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.14 |
string |
Gemeente |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.31 |
2017-03-30T15:30:34 |
NL-CM-0.1.16 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.16 |
string |
Land |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.32 |
2017-03-30T15:30:34 |
NL-CM-0.1.17 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.17 |
choice |
AdditioneleInformatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.33 |
2017-03-30T15:30:34 |
NL-CM-0.1.28 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.28 |
string |
AdresSoort |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.34 |
2017-03-30T15:30:34 |
NL-CM-0.1.11 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.11 |
choice |
OrganisatieType |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.35 |
2017-03-30T15:30:34 |
NL-CM-17.2.4 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.4 |
choice |
Aanvullend onderzoek |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.62 |
2017-03-30T15:30:34 |
onco-generic-dataelement-81 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-81 |
group |
Pathologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.78 |
2017-03-30T15:30:34 |
onco-generic-dataelement-119 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-119 |
group |
Cytologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.79 |
2017-03-30T15:30:34 |
onco-generic-dataelement-125 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-125 |
group |
Cytologie borstafwijking |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.80 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-80 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-80 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.81 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-81 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-81 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.82 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-82 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-82 |
choice |
Uitslag cytologie borstafwijking |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.83 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-83 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-83 |
choice |
Histologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.87 |
2017-03-30T15:30:34 |
onco-generic-dataelement-126 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-126 |
group |
Mammarcarcinoom |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.88 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-88 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-88 |
group |
Biopt |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.89 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-89 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-89 |
group |
Inzending |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.90 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-90 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-90 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.91 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-91 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-91 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.92 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-92 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-92 |
choice |
Afwijking |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.94 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-94 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-94 |
group |
Type afwijking |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.95 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-95 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-95 |
choice |
Morfologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.96 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-96 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-96 |
choice |
Graad |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.97 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-97 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-97 |
choice |
(Lymf-) angioinvasie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.98 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-98 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-98 |
choice |
Type invasieve tumor |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.99 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-99 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-99 |
choice |
Type in situ carcinoom |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.100 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-100 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-100 |
choice |
Microcalcificaties |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.101 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-101 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-101 |
choice |
Verdenking invasieve component bij DCIS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.102 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-102 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-102 |
choice |
Type niet eenduidig benigne laesie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.103 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-103 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-103 |
choice |
Verdenking op phyllodestumor |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.104 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-104 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-104 |
choice |
Receptor status |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.105 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-105 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-105 |
group |
ER-status |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.106 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-106 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-106 |
choice |
ER-percentage |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.107 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-107 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-107 |
quantity |
PR-status |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.108 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-108 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-108 |
choice |
PR-percentage |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.109 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-109 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-109 |
quantity |
HER2-status |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.110 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-110 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-110 |
choice |
HER2 Immunohistochemie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.111 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-111 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-111 |
choice |
HER2 CISH/SISH |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.112 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-112 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-112 |
choice |
HER2 FISH |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.113 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-113 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-113 |
choice |
HER2 PCR |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.114 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-114 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-114 |
choice |
Mammaprint |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.115 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-115 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-115 |
choice |
Radiologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.171 |
2017-03-30T15:30:34 |
onco-generic-dataelement-127 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-127 |
group |
Echo |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.175 |
2017-03-30T15:30:34 |
onco-generic-dataelement-139 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-139 |
group |
Echo borst |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.176 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-176 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-176 |
group |
Tumordistributie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.178 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-178 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-178 |
choice |
Laesie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.180 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-180 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-180 |
group |
Vorm |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.181 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-181 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-181 |
choice |
BI-RADS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.182 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-182 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-182 |
choice |
Diameter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.183 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-183 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-183 |
quantity |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.184 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-184 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-184 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.185 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-185 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-185 |
choice |
MRI |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.191 |
2017-03-30T15:30:34 |
onco-generic-dataelement-145 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-145 |
group |
MRI borst |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.192 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-192 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-192 |
group |
BI-RADS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.193 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-193 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-193 |
choice |
Verslag |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.194 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-194 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-194 |
string |
Tumordistributie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.195 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-195 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-195 |
choice |
T4 kenmerken aanwezig |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.196 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-196 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-196 |
choice |
Laesie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.197 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-197 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-197 |
group |
Vorm |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.198 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-198 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-198 |
choice |
BI-RADS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.199 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-199 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-199 |
choice |
Diameter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.200 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-200 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-200 |
quantity |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.201 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-201 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-201 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.202 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-202 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-202 |
choice |
Röntgen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.204 |
2017-03-30T15:30:34 |
onco-generic-dataelement-146 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-146 |
group |
Mammografie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.205 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-205 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-205 |
group |
BI-RADS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.206 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-206 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-206 |
choice |
Tumordistributie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.208 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-208 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-208 |
choice |
Solide component |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.209 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-209 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-209 |
choice |
Solide massa |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.210 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-210 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-210 |
choice |
Occulte massa |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.211 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-211 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-211 |
choice |
Calcificaties |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.212 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-212 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-212 |
choice |
Distributie calcificaties |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.213 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-213 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-213 |
choice |
Compositie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.214 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-214 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-214 |
choice |
Klinische verdenking phyllodestumor |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.215 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-215 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-215 |
choice |
Laesie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.216 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-216 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-216 |
group |
Begrenzing |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.217 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-217 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-217 |
choice |
Vorm |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.218 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-218 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-218 |
choice |
BI-RADS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.219 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-219 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-219 |
choice |
Diameter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.220 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-220 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-220 |
quantity |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.221 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-221 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-221 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.222 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-222 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-222 |
choice |
Multidisciplinair overleg |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.224 |
2017-03-30T15:30:34 |
onco-generic-dataelement-154 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-154 |
group |
Datum MDO-verslag akkoord |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.225 |
2017-03-30T15:30:34 |
onco-generic-dataelement-155 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-155 |
date |
Vraagstelling |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.226 |
2017-03-30T15:30:34 |
onco-generic-dataelement-156 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-156 |
string |
Aanwezigheid: specialismen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.227 |
2017-03-30T15:30:34 |
onco-generic-dataelement-157 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-157 |
choice |
Datum |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.229 |
2017-03-30T15:30:34 |
onco-generic-dataelement-160 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-160 |
date |
Diagnose en stadiëring |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.230 |
2017-03-30T15:30:34 |
onco-generic-dataelement-161 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-161 |
group |
Mammacarcinoom |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.231 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-231 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-231 |
group |
Initiele diagnostiek |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.232 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-232 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-232 |
group |
Zwanger |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.234 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-234 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-234 |
choice |
Borst |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.239 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-239 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-239 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.240 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-240 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-240 |
choice |
BI-RADS |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.241 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-241 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-241 |
choice |
Calcificaties in borst |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.242 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-242 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-242 |
choice |
Solide massa in borst |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.244 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-244 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-244 |
choice |
Solide component op mammografie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.245 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-245 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-245 |
choice |
Klinisch (cTNM) |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.246 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-246 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-246 |
group |
Tumor |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.247 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-247 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-247 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.248 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-248 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-248 |
choice |
Tumordistributie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.249 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-249 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-249 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.250 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-250 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-250 |
choice |
cT-diameter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.251 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-251 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-251 |
quantity |
cT4-kenmerken |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.252 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-252 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-252 |
choice |
Morfologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.253 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-253 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-253 |
choice |
Graad |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.254 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-254 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-254 |
choice |
cT |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.255 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-255 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-255 |
choice |
Receptorstatus |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.256 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-256 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-256 |
group |
ER-percentage |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.257 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-257 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-257 |
quantity |
PR-percentage |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.258 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-258 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-258 |
quantity |
HER2 status |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.259 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-259 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-259 |
choice |
Lymfeklieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.260 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-260 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-260 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.261 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-261 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-261 |
choice |
Gefixeerde axillaire klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.262 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-262 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-262 |
choice |
Klinisch positieve axillaire klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.263 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-263 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-263 |
choice |
Klinisch positieve parasternale klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.264 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-264 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-264 |
choice |
Klinisch positieve infraclaviculaire klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.265 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-265 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-265 |
choice |
Klinisch positieve supraclaviculaire klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.266 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-266 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-266 |
choice |
cN |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.267 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-267 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-267 |
choice |
Metastasen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.268 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-268 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-268 |
group |
Lokalisatie metastase |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.269 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-269 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-269 |
choice |
cM |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.270 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-270 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-270 |
choice |
Receptorstatus metastasen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.271 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-271 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-271 |
group |
ER-percentage metastase |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.272 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-272 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-272 |
quantity |
HER2 status metastase |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.273 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-273 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-273 |
choice |
cTNM |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.274 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-274 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-274 |
choice |
Beleid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.382 |
2017-03-30T15:30:34 |
onco-generic-dataelement-163 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-163 |
group |
Advies klinische studie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.414 |
2017-03-30T15:30:34 |
onco-generic-dataelement-164 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-164 |
choice |
Klinische studie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.415 |
2017-03-30T15:30:34 |
onco-generic-dataelement-165 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-165 |
string |
Beleid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.416 |
2017-03-30T15:30:34 |
onco-generic-dataelement-166 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-166 |
string |
Motivatie afwijken richtlijn |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.417 |
2017-03-30T15:30:34 |
onco-generic-dataelement-168 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-168 |
choice |
Motivatie afwijken richtlijn anders |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.418 |
2017-03-30T15:30:34 |
onco-generic-dataelement-169 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-169 |
string |